These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 288106)

  • 21. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
    Marroum MC; Huvos AG; Rosen G
    Oncology; 1977; 34(6):273-80. PubMed ID: 304199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy and thoractomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery.
    Rosen G; Huvos AG; Mosende C; Beattie EJ; Exelby PR; Capparos B; Marcove RC
    Cancer; 1978 Mar; 41(3):841-9. PubMed ID: 305817
    [No Abstract]   [Full Text] [Related]  

  • 23. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
    Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
    J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
    Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
    Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unusual Cause of Spontaneous Bilateral Pneumothorax Secondary to Osteosarcoma Metastasis.
    Sen BK; Basu M; Das S; Chaturvedi AN
    J Assoc Physicians India; 2016 Feb; 64(2):68-69. PubMed ID: 27730786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
    Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H
    J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapy of osteogenic sarcoma: current status and thoughts for the future.
    Friedman MA; Carter SK
    J Surg Oncol; 1972; 4(5):482-510. PubMed ID: 4566220
    [No Abstract]   [Full Text] [Related]  

  • 28. Current therapies in osteosarcoma.
    Handelsman H; Carter SK
    Cancer Treat Rev; 1975 Mar; 2(1):77-83. PubMed ID: 1102086
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone metastases from osteosarcoma.
    San-Julian M; Diaz-de-Rada P; Noain E; Sierrasesumaga L
    Int Orthop; 2003; 27(2):117-20. PubMed ID: 12700938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma.
    Lee JA; Kim MS; Kim DH; Lim JS; Yoo JY; Koh JS; Lee SY; Jeon DG; Park KD
    Pediatr Blood Cancer; 2008 Feb; 50(2):195-200. PubMed ID: 18061933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgery of osteosarcoma of the extremities: indications and complications in the recent experience at the Istituto Ortopedico Rizzoli.
    Ruggieri P; Biagini R; Bacci G; Ferraro A; Ferruzzi A; De Cristofaro R; Mercuri M; Picci P; Capanna R; Campanacci M
    Cancer Treat Res; 1993; 62():185-203. PubMed ID: 8096732
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
    Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
    Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
    Kager L; Zoubek A; Pötschger U; Kastner U; Flege S; Kempf-Bielack B; Branscheid D; Kotz R; Salzer-Kuntschik M; Winkelmann W; Jundt G; Kabisch H; Reichardt P; Jürgens H; Gadner H; Bielack SS;
    J Clin Oncol; 2003 May; 21(10):2011-8. PubMed ID: 12743156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor volume increase during preoperative chemotherapy as a novel predictor of local recurrence in extremity osteosarcoma.
    Song WS; Jeon DG; Kong CB; Cho WH; Koh JS; Lee JA; Yoo JY; Jung ST; Shin DS; Lee SY
    Ann Surg Oncol; 2011 Jun; 18(6):1710-6. PubMed ID: 21222166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy associated with surgery in the treatment of osteosarcoma. Preliminary results.
    Bacci G; Pagani PA; Donati U
    Ital J Orthop Traumatol; 1976 Dec; 2(3):363-74. PubMed ID: 1072874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The reproduction in France of Rosen's protocol for osteosarcomas].
    Brunat-Mentigny M; Demaille MC; Quitana E; Olive D; Bachelot C; Boitetot A; Gentet JC; Noir P; Roche H; Thyss JP
    Bull Cancer; 1988; 75(2):201-6. PubMed ID: 2451955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.
    Eilber F; Giuliano A; Eckardt J; Patterson K; Moseley S; Goodnight J
    J Clin Oncol; 1987 Jan; 5(1):21-6. PubMed ID: 3543236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periosteal osteosarcoma: a single-institution experience.
    Cesari M; Alberghini M; Vanel D; Palmerini E; Staals EL; Longhi A; Abate M; Ferrari C; Balladelli A; Ferrari S
    Cancer; 2011 Apr; 117(8):1731-5. PubMed ID: 21472720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteogenic sarcoma studies by the Cancer and Leukemia Group B.
    Cortes EP; Holland JF; Glidewell O
    Natl Cancer Inst Monogr; 1981 Apr; (56):207-9. PubMed ID: 7029290
    [No Abstract]   [Full Text] [Related]  

  • 40. Continuous-infusion ifosfamide and doxorubicin combination as second-line chemotherapy for recurrent or refractory osteosarcoma patients in China: a retrospective study.
    Huang YJ; He AN; Sun YJ; Shen Z; Min DL; Yao Y
    Asian Pac J Cancer Prev; 2015; 16(6):2391-5. PubMed ID: 25824770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.